These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 7525829)

  • 1. Insulin-like growth factors-I and -II and their binding proteins during postnatal development of dwarf Snell mice before and during growth hormone and thyroxine therapy.
    van Buul-Offers SC; Bloemen RJ; Reijnen-Gresnigt MG; van Leiden HA; Hoogerbrugge CM; Van den Brande JL
    J Endocrinol; 1994 Oct; 143(1):191-8. PubMed ID: 7525829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant insulin-like growth factor-II inhibits the growth-stimulating effect of growth hormone on the liver of Snell dwarf mice.
    van Buul-Offers SC; Reijnen-Gresnigt MG; Hoogerbrugge CM; Bloemen RJ; Kuper CF; Van den Brande JL
    Endocrinology; 1994 Sep; 135(3):977-85. PubMed ID: 7520865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pregnancy in growth hormone-deficient rats: assessment of insulin-like growth factors (IGFs), IGF-binding proteins (IGFBPs) and IGFBP protease activity.
    Gargosky SE; Nanto-Salonen K; Tapanainen P; Rosenfeld RG
    J Endocrinol; 1993 Mar; 136(3):479-89. PubMed ID: 7682593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ontogeny of pituitary regulation of growth in the developing rat: comparison of effects of hypophysectomy and hormone replacement on somatic and organ growth, serum insulin-like growth factor-I (IGF-I) and IGF-II levels, and IGF-binding protein levels in the neonatal and juvenile rat.
    Glasscock GF; Gin KK; Kim JD; Hintz RL; Rosenfeld RG
    Endocrinology; 1991 Feb; 128(2):1036-47. PubMed ID: 1703478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Administration of growth hormone (GH), but not insulin-like growth factor-I (IGF-I), by continuous infusion can induce the formation of the 150-kilodalton IGF-binding protein-3 complex in GH-deficient rats.
    Gargosky SE; Tapanainen P; Rosenfeld RG
    Endocrinology; 1994 May; 134(5):2267-76. PubMed ID: 7512499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IGFs and IGF-binding proteins in short children with steroid-dependent nephrotic syndrome on chronic glucocorticoids: changes with 1 year exogenous GH.
    Zhou X; Loke KY; Pillai CC; How HK; Yap HK; Lee KO
    Eur J Endocrinol; 2001 Mar; 144(3):237-43. PubMed ID: 11248742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of continuous infusion of insulin-like growth factor I and II, alone and in combination with thyroxine or growth hormone, on the neonatal hypophysectomized rat.
    Glasscock GF; Hein AN; Miller JA; Hintz RL; Rosenfeld RG
    Endocrinology; 1992 Jan; 130(1):203-10. PubMed ID: 1370151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The composition and distribution of insulin-like growth factors (IGFs) and IGF-binding proteins (IGFBPs) in the serum of growth hormone receptor-deficient patients: effects of IGF-I therapy on IGFBP-3.
    Gargosky SE; Wilson KF; Fielder PJ; Vaccarello MA; Guevara-Aguirre J; Diamond FB; Baxter RC; Rosenbloom AL; Rosenfeld RG
    J Clin Endocrinol Metab; 1993 Dec; 77(6):1683-9. PubMed ID: 7505289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of thyroxine administration on the IGF/IGF binding protein system in neonatal and adult thyroidectomized rats.
    Ramos S; Goya L; Alvarez C; Martín MA; Pascual-Leone AM
    J Endocrinol; 2001 Apr; 169(1):111-22. PubMed ID: 11250652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complex pattern of insulin-like growth factor binding protein expression in primary rat osteoblast enriched cultures: regulation by prostaglandin E2, growth hormone, and the insulin-like growth factors.
    McCarthy TL; Casinghino S; Centrella M; Canalis E
    J Cell Physiol; 1994 Jul; 160(1):163-75. PubMed ID: 7517403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The insulin-like growth factor (IGF)-binding proteins and IGF bioactivity in Laron-type dwarfism.
    Cotterill AM; Holly JM; Taylor AM; Davies SC; Coulson VJ; Preece MA; Wass JA; Savage MO
    J Clin Endocrinol Metab; 1992 Jan; 74(1):56-63. PubMed ID: 1370165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of thyroid hormone action on the insulin-like growth factor system: all thyroid hormone effects are not growth hormone mediated.
    Näntö-Salonen K; Muller HL; Hoffman AR; Vu TH; Rosenfeld RG
    Endocrinology; 1993 Feb; 132(2):781-8. PubMed ID: 7678799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ontogeny of insulin-like growth factors (IGF-I and IGF-II) and IGF-binding proteins in porcine serum during fetal and postnatal development.
    Lee CY; Bazer FW; Etherton TD; Simmen FA
    Endocrinology; 1991 May; 128(5):2336-44. PubMed ID: 1708333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid clearance of insulin-like growth factor (IGF)-binding protein species from blood and an associated fall in circulating IGF-I following partial hepatectomy in the rat.
    Phillips ID; Arany E; Strain AJ; Han VK; Hill DJ
    J Endocrinol; 1993 May; 137(2):271-80. PubMed ID: 7686958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of insulin-like growth factor (IGF) binding proteins in transgenic mice with altered expression of growth hormone and IGF-I.
    Camacho-Hubner C; Clemmons DR; D'Ercole AJ
    Endocrinology; 1991 Sep; 129(3):1201-6. PubMed ID: 1714829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of insulin-like growth factor binding proteins (IGFBPs) during gestation in mice: effects of hypophysectomy and an IGFBP-specific serum protease activity.
    Fielder PJ; Thordarson G; Talamantes F; Rosenfeld RG
    Endocrinology; 1990 Nov; 127(5):2270-80. PubMed ID: 1699743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth hormone insensitivity syndromes: a preliminary report on changes in insulin-like growth factors and their binding proteins during treatment with recombinant insulin-like growth factor I. Kabi Pharmacia Study Group on Insulin-like Growth Factor I Treatment in Growth Hormone Insensitivity Syndromes.
    Blum WF; Hall K; Ranke MB; Wilton P
    Acta Paediatr Suppl; 1993 Sep; 82 Suppl 391():15-9. PubMed ID: 7693071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversible effects of cessation and recommencement of thyroxine treatment on insulin-like growth factors (IGFs) and IGF-binding proteins in patients with total thyroidectomy.
    Miell JP; Zini M; Quin JD; Jones J; Portioli I; Valcavi R
    J Clin Endocrinol Metab; 1994 Nov; 79(5):1507-12. PubMed ID: 7525638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth hormone deficiency in 'little' mice results in aberrant body composition, reduced insulin-like growth factor-I and insulin-like growth factor-binding protein-3 (IGFBP-3), but does not affect IGFBP-2, -1 or -4.
    Donahue LR; Beamer WG
    J Endocrinol; 1993 Jan; 136(1):91-104. PubMed ID: 7679139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human insulin-like growth factor (IGF) binding protein-1 inhibits IGF-I-stimulated body growth but stimulates growth of the kidney in snell dwarf mice.
    Van Buul-Offers SC; Van Kleffens M; Koster JG; Lindenbergh-Kortleve DJ; Gresnigt MG; Drop SL; Hoogerbrugge CM; Bloemen RJ; Koedam JA; Van Neck JW
    Endocrinology; 2000 Apr; 141(4):1493-9. PubMed ID: 10746655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.